Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-215.41%
operating margin TTM
-210.66%
revenue TTM
8.31 Million
revenue per share TTM
0.13$
valuation ratios | |
|---|---|
| pe ratio | -1.63 |
| peg ratio | -0.04 |
| price to book ratio | 1.12 |
| price to sales ratio | 3.86 |
| enterprise value multiple | -1.35 |
| price fair value | 1.12 |
profitability ratios | |
|---|---|
| gross profit margin | 74.97% |
| operating profit margin | -210.66% |
| pretax profit margin | -211.5% |
| net profit margin | -215.41% |
| return on assets | -29.46% |
| return on equity | -57.31% |
| return on capital employed | -31.22% |
liquidity ratios | |
|---|---|
| current ratio | 5.15 |
| quick ratio | 5.15 |
| cash ratio | 1.81 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 51.18 |
| days of payables outstanding | 168.30 |
| cash conversion cycle | -117.11 |
| receivables turnover | 7.13 |
| payables turnover | 2.17 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.40 |
| debt equity ratio | 0.93 |
| long term debt to capitalization | 0.48 |
| total debt to capitalization | 0.48 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -0.40 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.08 |
| cash per share | 6.27 |
| operating cash flow per share | -2.79 |
| free cash flow operating cash flow ratio | 1.10 |
| cash flow coverage ratios | -0.40 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -9.60 |
Frequently Asked Questions
When was the last time Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) reported earnings?
Ginkgo Bioworks Holdings, Inc. (DNA) published its most recent earnings results on 07-05-2026.
What is Ginkgo Bioworks Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)'s trailing twelve months ROE is -57.31%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ginkgo Bioworks Holdings, Inc. (DNA) currently has a ROA of -29.46%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did DNA's net profit margin stand at?
DNA reported a profit margin of -215.41% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is DNA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.15 in the most recent quarter. The quick ratio stood at 5.15, with a Debt/Eq ratio of 0.93.